Home - Boston Life Sciences Times

Elucid’s Plaque-IQ Wins MedTech Breakthrough Cardiology Technology Award

May 7, 2026

City Therapeutics Reports Preclinical Data for Stargardt Disease RNAi Therapy

May 6, 2026

Sail Biomedicines Names Gene Marcantonio Chief Medical Officer

May 5, 2026

THIS WEEK'S STORIES

Thermo Fisher Launches Bioreactor Platform for Scalable Cell Therapy Manufacturing

May 4, 2026

Rejoni Names John Nealon Chief Executive Officer

May 4, 2026

Ukko Doses First Participant in Peanut Allergy Treatment Study

May 7, 2026

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Most Popular

Museum of Science Raises Record $1.8 Million at Stars of STEM Gala

enGene Reports Updated Interim Results From Bladder Cancer Trial

Elucid’s Plaque-IQ Wins MedTech Breakthrough Cardiology Technology Award

Scholar Rock Reports First-Quarter Results as FDA Review of Apitegromab Advances

Recent Comments

EDITOR PICKS

Elucid’s Plaque-IQ Wins MedTech Breakthrough Cardiology Technology Award

City Therapeutics Reports Preclinical Data for Stargardt Disease RNAi Therapy

Sail Biomedicines Names Gene Marcantonio Chief Medical Officer

THIS WEEK'S STORIES

Thermo Fisher Launches Bioreactor Platform for Scalable Cell Therapy Manufacturing

Rejoni Names John Nealon Chief Executive Officer

Ukko Doses First Participant in Peanut Allergy Treatment Study

POPULAR CATEGORY

ABOUT US

FOLLOW US

LATEST ARTICLES

Most Popular

Recent Comments

EDITOR PICKS

THIS WEEK'S STORIES

POPULAR CATEGORY

ABOUT US

FOLLOW US